Business Context and Reporting Period
This Form 8-K is a current report filed by Medtronic plc on December 14, 2021. The filing addresses a specific corporate governance event regarding the departure of a senior executive.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The material change reported is the announced retirement of Richard Kuntz, M.D., Senior Vice President and Chief Medical and Scientific Officer. Dr. Kuntz notified the company on December 14, 2021, that he will retire effective April 29, 2022. He has served on the executive committee since 2005, marking an over 15-year tenure at Medtronic and a 40-year career in medicine.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, management commentary on market conditions, or specific risk factors. The document is limited to the notification of the executive's departure.
Investor Verification Checklist
- Verify the effective date of Dr. Kuntz's retirement (April 29, 2022).
- Confirm the appointment of a successor for the Chief Medical and Scientific Officer role.
- Review subsequent filings for any changes to the executive committee structure.